European Shares Rebound on Ceasefire Hopes and Inflation Relief

European shares rebounded on optimism over developments in the Ukraine-Russia conflict and a cooler U.S. inflation report. A 30-day ceasefire proposal between Ukraine and Russia and U.S. support helped sentiment. Zealand Pharma and Roche's deal boosted healthcare, while Puma's downturn impacted retail.

European shares experienced a rebound on Wednesday, fueled by positive speculations surrounding the Ukraine-Russia conflict and a cooler-than-expected U.S. inflation report. The pan-European STOXX 600 index rose by 0.8%, ending a four-session losing streak.

The U.S. resumed military aid to Ukraine after the latter expressed willingness to consider a 30-day ceasefire with Russia, spurring optimism. Fiona Cincotta, senior market analyst at City Index, noted potential reductions in European energy costs and other benefits if peace talks progress.

Zealand Pharma saw a historic 37% rise after Roche acquired rights to one of its obesity therapies, while Puma's shares plummeted due to poor quarterly projections. Meanwhile, U.S. President Trump's trade tariff decisions created market volatility, further addressed by counter-measures from Europe and Canada.

(With inputs from agencies.)